CN1634276A - Chinese traditional medicine for treating disc protrusion and hyperosteogeny - Google Patents
Chinese traditional medicine for treating disc protrusion and hyperosteogeny Download PDFInfo
- Publication number
- CN1634276A CN1634276A CN 200410044027 CN200410044027A CN1634276A CN 1634276 A CN1634276 A CN 1634276A CN 200410044027 CN200410044027 CN 200410044027 CN 200410044027 A CN200410044027 A CN 200410044027A CN 1634276 A CN1634276 A CN 1634276A
- Authority
- CN
- China
- Prior art keywords
- grams
- radix
- hyperosteogeny
- root
- chinese traditional
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a Chinese traditional medicine for treating disc protrusion and hyperosteogeny which comprises frankincense, myrrh, rhizoma corydalis, Sichuan aconite root, Kusnezoff monkshood root, fresh ginger, pangolin scales, achyranthes and cyathula root, notoginseng, dragon's blood resin, wood louse, dipsacus root, cucumber seeds, safflower, spatholobus stem, scorpion, tetrandra root, medicated leaven, and plantain seeds.
Description
Technical field
The invention belongs to technical field of Chinese medicines, be specifically related to a kind of Chinese medicine for the treatment of orthopaedic disease.
Background technology
Announce that according to the health department authoritative department multiple in recent years common disease morbidity crowd rejuvenation is in rising trend, particularly patient such as " prolapse of lumbar intervertebral disc ", " hyperosteogeny ", " fracture back sclerotin injury " particularly increases.Existing Therapeutic Method is a lot, but owing to western medical treatment expense height, painful big and recurrence easily; Utilization Chinese patent drugs for treatment performance is single, curative effect long, effect slowly, be difficult to factor such as radical cure, cause a lot of patients to can not be restored.
Summary of the invention
The Chinese medicine of the object of the present invention is to provide a kind of short treating period, curative effect is fast and more the back is difficult for recurrence, obvious results treatment intervertebral disk hernia, hyperosteogeny.
It is monarch drug that Chinese medicine of the present invention is selected Flos Carthami, Caulis Spatholobi, Radix Notoginseng, Sanguis Draxonis, Olibanum, Myrrha, Rhizoma Corydalis, Squama Manis, has the effect of invigorating blood circulation blood stasis dispelling, dredge the meridian passage; Radix Aconiti, Radix Aconiti Kusnezoffii, drynaria baronii, Eupolyphaga Seu Steleophaga, Semen Strychni (processed), Radix Dipsaci, Semen Cucumidis sativi, Scorpio, Radix Stephaniae Tetrandrae are ministerial drug, have the effect of expelling wind and removing dampness, removing obstruction in the collateral to relieve pain; Radix Cyathulae is an adjuvant drug, and priming is descending; Massa Medicata Fermentata is a messenger drug, and promote qi circulation digestion promoting, spleen benefiting and stimulating the appetite are to help digesting and assimilating of medicine.
Chinese medicine of the present invention is made by the following raw materials in weight medicine: Olibanum 30 grams, Myrrha 30 grams, Rhizoma Corydalis 30 grams, Radix Aconiti 30 grams, Radix Aconiti Kusnezoffii 30 grams, Eumeces Chinensis 30 grams, drynaria baronii 20 grams, Squama Manis 20 grams, Radix Cyathulae 20 grams, Radix Notoginseng 20 grams, Sanguis Draxonis 20 grams, Eupolyphaga Seu Steleophaga 20 grams, Radix Dipsaci 20 grams, Semen Cucumidis sativi 20 grams, Flos Carthami 20 grams, Caulis Spatholobi 30 grams, Scorpio 15 grams, Radix Stephaniae Tetrandrae 20 grams, Massa Medicata Fermentata 30 grams and Semen Strychni (processed) 15 grams.
Preparation method: become smalls promptly in above-mentioned raw materials medicated powder.
The all medicines of the present invention share, and supplement and complement each other, and play drug effect altogether, agree with pathogenesis, and curative effect brings out the best in each other, and have the effect of blood circulation promoting and blood stasis dispelling, dredge the meridian passage, wind-expelling pain-stopping.Chinese medicine of the present invention is mainly used in treatment prolapse of lumbar intervertebral disc, prolapse of cervical intervertebral disc, hyperosteogeny, also can treat fracture back sclerotin injury.
The specific embodiment
The clinical observation of sclerotin injury after treatment by Chinese herbs intervertebral disk hernia of the present invention, hyperosteogeny, the fracture
1. physical data
Accept out-patient's totally 100 examples for medical treatment, male's 46 examples wherein, women's 54 examples, age 26-65 year.Prolapse of lumbar intervertebral disc patient 34 examples wherein, prolapse of cervical intervertebral disc patient 26 examples, hyperosteogeny patient's 28 examples, fracture back sclerotin injury patient 12 examples.
2. diagnostic criteria
Flank pain shows as and stands up or difficulty in walking, cough, sneeze or stool all can be increased the weight of firmly the time; The lower limb radiating pain, the big leg outer side or the shank outside present bilateral or replace property pain; The lumbar vertebra tenderness is one of localized means of diagnosis; Straight lower limb is raised experiment and is positive, and tendon reflex changes, and quadriceps reflex lowers, and Achilles tendon reflex weakens; Cauda equina nerve compressing syndrome: large and small just dysfunction can occur, sexual dysfunction; The CT diagnosis.
3. Therapeutic Method
Powder, every day three times, each 5 grams, are taken 1-2 the course of treatment at 30 days course of treatment.
4. curative effect determinate standard
Cure: the symptom and sign complete obiteration of treatment back, waist is movable normal.
Produce effects: symptom and sign disappears substantially, and recovered part work still has slight discomfort.
Invalid: the treatment no any change in back.
5. therapeutic outcome
Prolapse of lumbar intervertebral disc patient cures 31 examples, produce effects 3 examples; The prolapse of cervical intervertebral disc patient cures 20 examples, produce effects 6 examples; Hyperosteogeny patient cures 23 examples, produce effects 5 examples; Fracture back sclerotin injury patient 12 examples are all cured.Cure 86 examples altogether, effective 14 examples, cure rate 86%, obvious effective rate 14%, total effective rate 100%.
Claims (1)
1, a kind of Chinese medicine for the treatment of intervertebral disk hernia, hyperosteogeny is characterized in that it is to be made by the following raw materials in weight medicine: Olibanum 30 grams, Myrrha 30 grams, Rhizoma Corydalis 30 grams, Radix Aconiti 30 grams, Radix Aconiti Kusnezoffii 30 grams, Eumeces Chinensis 30 grams, drynaria baronii 20 grams, Squama Manis 20 grams, Radix Cyathulae 20 grams, Radix Notoginseng 20 grams, Sanguis Draxonis 20 grams, Eupolyphaga Seu Steleophaga 20 grams, Radix Dipsaci 20 grams, Semen Cucumidis sativi 20 grams, Flos Carthami 20 grams, Caulis Spatholobi 30 grams, Scorpio 15 grams, Radix Stephaniae Tetrandrae 20 grams, Massa Medicata Fermentata 30 grams and Semen Strychni (processed) 15 grams.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410044027 CN1281253C (en) | 2004-11-08 | 2004-11-08 | Chinese traditional medicine for treating disc protrusion and hyperosteogeny |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410044027 CN1281253C (en) | 2004-11-08 | 2004-11-08 | Chinese traditional medicine for treating disc protrusion and hyperosteogeny |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1634276A true CN1634276A (en) | 2005-07-06 |
| CN1281253C CN1281253C (en) | 2006-10-25 |
Family
ID=34845954
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200410044027 Expired - Fee Related CN1281253C (en) | 2004-11-08 | 2004-11-08 | Chinese traditional medicine for treating disc protrusion and hyperosteogeny |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1281253C (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101385801B (en) * | 2008-10-22 | 2012-05-23 | 刘学俊 | Traditional Chinese medicine preparation for treating hyperosteogeny |
| CN104013686A (en) * | 2014-06-24 | 2014-09-03 | 黄加利 | Drug for treating lumbar disc herniation and preparation method thereof |
-
2004
- 2004-11-08 CN CN 200410044027 patent/CN1281253C/en not_active Expired - Fee Related
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101385801B (en) * | 2008-10-22 | 2012-05-23 | 刘学俊 | Traditional Chinese medicine preparation for treating hyperosteogeny |
| CN104013686A (en) * | 2014-06-24 | 2014-09-03 | 黄加利 | Drug for treating lumbar disc herniation and preparation method thereof |
| CN104013686B (en) * | 2014-06-24 | 2016-01-20 | 黄加利 | A kind of medicine being used for the treatment of prolapse of lumbar intervertebral disc and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1281253C (en) | 2006-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102488869A (en) | Traditional Chinese medicinal external-use liniment for muscle and bone ache | |
| CN101361872A (en) | Traditional Chinese medicine for quickly treating bone fracture and postoperative nonunion and delayed healing | |
| CN101049351A (en) | Composition of Chinese traditional medicine for treating prolapse of lumbar intervertebral disc | |
| CN103479837B (en) | External medicine for curing hyperosteogeny and preparation method thereof | |
| CN101007040B (en) | External applied medicine for treating bone fractures | |
| CN1069527C (en) | Medicine for hyperosteogeny and wind-cold syndrome | |
| CN1555857A (en) | Medicinal plaster for treating sinew and bone tissue injury pain, bone fracture, dislocation | |
| CN101342290B (en) | Tong bi liquid and preparation method thereof | |
| CN101327259B (en) | Medicament for treating protrusion of lumbar vertebral disc | |
| CN1883575A (en) | Chinese medicine for treating hyperosteogeny | |
| CN102614351A (en) | Black plaster for treating osteoarthrosis | |
| CN102078586A (en) | Medicament for treating cervical spondylosis | |
| CN1281253C (en) | Chinese traditional medicine for treating disc protrusion and hyperosteogeny | |
| CN114796325A (en) | Traditional Chinese medicine composition for treating knee osteoarthritis and preparation method and application thereof | |
| CN102406870A (en) | Medicament for treating rheumatic arthralgia | |
| CN104491324A (en) | Aerosol for postoperative patient to promote blood circulation and remove obstruction in channels | |
| CN105233265A (en) | Composition capable of promoting wound healing | |
| CN100579547C (en) | Orally taken Chinese medicine composition for treating thromboangitis obliterans | |
| CN1850238A (en) | Medicine composition for treating backbone and joint disease | |
| CN102614350A (en) | Chinese medicine for treating cervical spondylosis | |
| CN109966451A (en) | A kind of Chinese medicine composition of bone-setting and pain-relieving | |
| CN101954043A (en) | Medicament for treating hyperosteogeny and preparation method thereof | |
| CN102430018A (en) | Medicinal composition for treating rheumatic and rheumatoid arthritis | |
| CN1216622C (en) | Ointment for intervertebral disc | |
| CN105233266A (en) | Spray for promoting wound healing |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20061025 Termination date: 20151108 |
|
| EXPY | Termination of patent right or utility model |